IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Lonza to Co-Develop Novartis Biologics Pipeline

12:17 PM MDT | July 21, 2008 | Deepti Ramesh

Lonza says it has entered into a long-term partnership with Novartis to jointly develop and manufacture Novartis’s biologics pipeline. Under the deal, Lonza will provide services from its R&D center at Slough, U.K. using its GS Gene Expression System as well as its large-scale manufacturing capacity from operations in Singapore, Spain, and the U.S. Kutzer: A change in approach. Novartis says it aims to further grow its biologics pipeline, which has risen during the last few years to about one-quarter of its total R&D portfolio. Novartis says its...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa